Collagen Technology Articles & Analysis: Older
2 news found
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced a definitive agreement to acquire privately held Biorez, Inc. (Biorez), on a cash-free, debt-free basis, for cash consideration of $85 million at closing, subject to adjustment, and up to an additional $165 million in growth-based earnout payments over a four-year period. The transaction is expected to be ...
The RCSI licensing deal includes best in class, proprietary, natural collagen-based delivery technologies, which have been developed into products for the regeneration of bone, the treatment of infection and regeneration of cartilage tissues. Locate Bio’s ambition is to build a world leading, diversified orthobiologics company with a suite of ...